3.8 Article

Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction

期刊

IJC HEART & VASCULATURE
卷 48, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcha.2023.101250

关键词

Cardiac troponin; Cardiac biomarkers; Kinetics; Myocardial infarction; Coronary artery disease; Cohort study

向作者/读者索取更多资源

This study aims to examine the changes in concentration, time-to-peak, and half-life of cardiac biomarkers in patients with myocardial infarction. Blood samples were collected every three hours within 24 hours after percutaneous coronary intervention (PCI) in patients with ST elevation myocardial infarction. The results showed no notable differences in time-to-peak or half-life between different high-sensitivity cardiac troponin (hs-cTn) assays.
Objective: To examine changes in concentration, time-to-peak and the ensuing half-life of cardiac biomarkers in patients with myocardial infarction.Methods: Blood sampling was performed every third hour within 24 h after percutaneous coronary intervention (PCI) on a cohort of patients with ST elevation myocardial infarction. Cardiac troponin (cTn) was measured by the Dimension Vista, Vitros, Atellica, and Alinity high-sensitivity (hs) cTnI assays, and the Elecsys hs-cTnT assay. Further, creatine kinase (CK), myoglobin, creatine kinase MB (CKMB) and other biomarkers were analyzed.Results: A total of 36 patients completed blood sampling (median age 60 years, IQR 56.4-66.5 years; seven women, 19.4%). Hs-cTnI measured by the Vitros assay was the first hs-cTn to peak at 9.1 h (95%-CI 6.2-10.1) after PCI and 11.7 h (95%-CI 10.4-14.8) after symptoms onset. There were no notable differences between hs-cTn assays in regard to time-to-peak. Also, Vitros hs-cTnI reached the highest median ratio of concentration to upper reference level of nearly 2,000. The median half-life from peak concentration ranged from 7.6 h for myoglobin (CI 6.8-8.6) to 17.8 h for CK (CI 6.8-8.6). For hs-cTn assays the median T1/2 ranged from 12.4 h for the Vista hs-cTnI assay (95%-CI 11.0-14.1 h) to 17.3 h for the Elecsys hs-cTnT (95%-CI 14.9-20.8 h).Conclusions: This study updates knowledge on the kinetics of cardiac biomarkers in current clinical use. There was no notable difference in trajectories, time-to-peak or half-life between hs-cTn assays.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据